EAMAS - Associazione Europea amici della Sindrome di McCune-Albright

European Association Friends of Mc Cune Albright Syndrome

Scegli la lingua:

Contatta EAMAS


Che cos'è EAMAS
Patologie trattate
Esperienze personali
Medici e ospedali
Link utili
Novità dell'associazione
Conferenze e simposi
Come finanziare EAMAS

Sponsor dell'anno

Ultimo aggiornamento:

Best view 1024 x 768
Ottimizzato per IE




Elenco completo

Elenco completo

Bisphosphonates: pharmacology, mechenism of action and clinical usesRussel RG, Croucher PI, Rogers MJ,Osteoporosis Int19999 (Suppl 2)S66en
Molecular mechanisms of action of bisphosphonatesRogers MJ, Firth JC, Luckman SP, Coxon FP, Benford HL, Monkkonen J, Auriola S, Chilton KM, Russel RG,Bone19992473S-79Sen
Preliminary result on pamidronate therapy in children suffering from osteogenesis imperfectaCoppin C, Maes M, Devogelaer JP,First International Conference on Children's Bone Health1999Abst P-15en
Pamidronate therapy in a child with osteogenesis imperfectaGoksen D, Coker M, Darcan S, Ozyurek R, Levent E, Dorak C, Parlar A,First International Conference on Children's Bone Health1999Abst P-55en
Progress in the prevention and treatment of osteoporosis in pediatricsSentongo TA, Haber B,J Pediatr Gastroenterol Nutr199928348-349en
Bisphosphonate therapy for polyostotic syndromeZacharin M,First International Conference on Children's Bone Health1999Abst P-28en
Bishphosphonates: from the laboratory to the clinic and back againRussel RG, Rogers MJ,Bone19992597-106en
The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gsalpha gene: site- specific patterns and recurrent histological hallmarksRiminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, Bianco P,J Pathol1999187249-258en
An animal model of fibrous dysplasiaBianco P, Robey PG,Mol Med Today19995322-323en
McCune-Albright syndrome: new insightsCollins Mt, Shenker A,Curr Opin Endocrinol Diabetes19996119-125en
Clinical implications of genetic defects in G proteins: oncogenic mutations in Gas as the molecular basis for the McCune-Albright syndromeLevine MA,Arch Med Res199930522-531en
Use of aromatase inhibitors in precocious pubertyFaullian P, Merke D, Leschek EW, Cutler GB Jr,Endocr Relat Cancer19996303-306en
Torsion of a functional ovarian cyst in a premenopausal patient receiving tamoxifenNasu K, Miyazaki T, Kiyonaga Y, Kawasaki J, Miyakawa I,Gynecol Obstet Invest199948200-202en
The luteinizing hormone receptorDufau ML,Annu Rev Physiol199860461-496en
Activating and inactivating mutations in LH receptorsThemmen AP, Martens JW, Brunner HG,Mol Cell Endocrinol1998145137-142en
Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumorsFragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS , Frazzatto ET, Mendonca BB, Villares SM,J Clin Endocrinol Metab1998832074-2078en
No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumorsFuller PJ, Verity K, Shen Y, Mamers P, Jobling T, Burger HG,J Clin Endocrinol Metab199883274-279en
Wirkung von Pamidronat auf Bescwerdebild und Knochenstoffwechsel bei fibroser Dysplasie und McCune-Albright-SyndromPfeilschifter J, Ziegler R,Med Klin199893352-359de
Gonadotropin independent precocious pubertyLow LCK, Wang Q,Journal of Pediatric Endocrinology & Metabolism (JPEM)199811497-507en
Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogueSchimdt H, Kiess W,Journal of Pediatric Endocrinology & Metabolism (JPEM)19981177-81en

Righe 20 di 186
Pagine: [ 1 ] [ 2 ] [ 3 ] [  4  ] [ 5 ] [ 6 ] [ 7 ] [ 8 ] [ 9 ] [ 10 ] 



Non hai una password?

Scordato la password?
Perchè iscriversi?
Consigli di utilizzo

Contatta EAMAS
Associarsi ad EAMAS
Contatta il web master

EAMAS - Associazione Europea amici della Sindrome di McCune-Albright
Via Borgovecchio, 25 - 10041 Carignano (TO) - Italy - Tel:+39 011-9697258 - Fax:+39 011-9697258